Aprea Therapeutics Announces Acquisition of Atrin Pharmaceuticals Inc. and Reports First Quarter 2022 Financial Results
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Greg Korbel News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Greg Korbel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Greg Korbel Today - Breaking & Trending Today
Aprea Therapeutics to Participate in the 2021 Oppenheimer Rare & Orphan Disease Summit
Published: May 21, 2021 BOSTON, May 21, 2021 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53, today announced that Greg Korbel, Senior Vice President and Chief Business Officer, will present a corporate update at the 2021 Oppenheimer Rare & Orphan Disease Summit on Friday, May 21, 2021 at 3:45 p.m. ET. A webcast of the presentation can be accessed from the “Events Calendar” in the News and Events section of the Aprea website...
Source: biospace.com